Traws Pharma, Inc. (TRAW) Balance Sheet
TRAW balance sheet, 2025
December 31, 2025 · U.S. dollars$10.6M assets = $11.2M liabilities + −$629,000 equity
Liabilities exceed assets: shareholders’ equity is negative (−$629,000).
Both columns are drawn to the same scale: what TRAW owns equals what it owes plus shareholders’ equity. Hover a block for its value.
TRAW financial health
Descriptive bands, not a rating. Fiscal 2025.
TRAW balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $23.2M2016 | $10.6M2025 | −8.3%/yr | |
| Total liabilities | $18.1M2016 | $11.2M2025 | −5.2%/yr | |
| Shareholders’ equity | $4.3M2016 | −$629,0002025 | — | |
| Cash & short-term investments | $21.4M2016 | $3.8M2025 | −17.4%/yr | |
| Working capital | $12.9M2016 | −$3.2M2025 | −$16.1M | |
| Current ratio | 2.272016 | 0.722025 | −1.55 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
TRAW assets
TRAW liabilities and equity
TRAW debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
TRAW balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $3.8M | $21.3M | $20.8M | $38.8M | $55.1M | $19.0M | $22.7M | $17.0M | $4.0M | $21.4M |
| Cash & equivalents | $3.8M | $21.3M | $20.8M | $38.8M | $55.1M | $19.0M | $22.7M | $17.0M | $4.0M | $21.4M |
| Receivables | $3.8M | $1.8M | $18,000 | $29,000 | $28,000 | $37,000 | $98,000 | $35,000 | $59,000 | $31,000 |
| Inventory | $0 | $0 | $1.4M | $521,000 | $297,000 | $542,000 | $0 | $0 | $0 | $0 |
| Other current assets | $365,000 | $1.8M | $401,000 | $40,000 | $35,000 | $180,000 | $650,000 | $760,000 | $820,000 | $1.6M |
| Total current assets | $8.0M | $25.0M | $22.7M | $39.3M | $55.4M | $19.8M | $23.5M | $17.8M | $4.9M | $23.1M |
| Property, plant & equipment (net) | $7,000 | $10,000 | $22,000 | $24,000 | $38,000 | $52,000 | $50,000 | $9,000 | $64,000 | $152,000 |
| Goodwill & intangible assets | $2.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $104,000 | $1,000 | $1,000 | $1,000 | $10,000 | $150,000 | $150,000 | $149,000 | $12,000 | $12,000 |
| Total assets | $10.6M | $25.0M | $22.7M | $39.4M | $55.5M | $20.0M | $23.7M | $17.9M | $5.0M | $23.2M |
| Liabilities | ||||||||||
| Accounts payable | $5.7M | $8.2M | $5.6M | $3.9M | $2.8M | $4.8M | $4.3M | $4.0M | $6.2M | $5.3M |
| Deferred revenue | — | $226,000 | $226,000 | $226,000 | $226,000 | $226,000 | $226,000 | $226,000 | $455,000 | $455,000 |
| Total current liabilities | $11.1M | $11.5M | $9.2M | $8.0M | $6.1M | $10.0M | $8.3M | $8.4M | $10.0M | $10.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $100,000 | $45.1M | $2.8M | $3.0M | $3.2M | $3.8M | $3.8M | $4.1M | $5.9M | $7.9M |
| Total liabilities | $11.2M | $56.6M | $12.0M | $11.1M | $9.4M | $13.8M | $12.1M | $12.5M | $15.8M | $18.1M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $90,000 | $36,000 | $210,000 | $209,000 | $209,000 | $124,000 | $1.1M | $57,000 | $8,000 | $68,000 |
| Retained earnings (deficit) | −$640.0M | −$649.2M | −$482.6M | −$463.7M | −$444.7M | −$428.6M | −$403.4M | −$381.9M | −$362.3M | −$338.2M |
| Accumulated other comprehensive income | $6,000 | −$42,000 | −$23,000 | −$33,000 | −$14,000 | $14,000 | −$18,000 | −$12,000 | $3,000 | −$31,000 |
| Total shareholders' equity | −$629,000 | −$31.6M | $10.7M | $28.3M | $46.1M | $6.2M | $11.6M | $5.4M | −$11.7M | $4.3M |
| Key figures | ||||||||||
| Working capital | −$3.2M | $13.4M | $13.4M | $31.3M | $49.3M | $9.8M | $15.2M | $9.3M | −$5.1M | $12.9M |
| Tangible book value | −$3.2M | −$31.6M | $10.7M | $28.3M | $46.1M | $6.2M | $11.6M | $5.4M | −$11.7M | $4.3M |
| Book value per share | −$0.08 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 8.4M | — | — | — | — | — | — | — | — | — |
| Current ratio | 0.72 | 2.16 | 2.46 | 4.89 | 9.06 | 1.97 | 2.83 | 2.11 | 0.49 | 2.27 |
| Quick ratio | 0.68 | 2.00 | 2.26 | 4.82 | 9.01 | 1.90 | 2.75 | 2.02 | 0.41 | 2.11 |
| Equity / assets | −5.9% | −126.7% | 47.0% | 71.9% | 83.1% | 30.9% | 48.9% | 30.1% | −234.8% | 18.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $5.0M | $3.1M | $3.8M | $6.4M | $13.1M | $15.9M | $21.3M | $5.4M | $16.9M | $16.4M | $20.8M | $25.2M |
| Cash & equivalents | $5.0M | $3.1M | $3.8M | $6.4M | $13.1M | $15.9M | $21.3M | $5.4M | $16.9M | $16.4M | $20.8M | $25.2M |
| Receivables | $0 | $1.7M | $3.8M | $2.0M | $1.3M | $1.7M | $1.8M | $2.1M | $18,000 | $18,000 | $18,000 | $18,000 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.4M | $1.4M | $1.4M |
| Other current assets | $4.0M | $845,000 | $365,000 | $1.2M | $966,000 | $1.3M | $1.8M | $1.4M | $1.8M | $325,000 | $401,000 | $303,000 |
| Total current assets | $9.0M | $5.7M | $8.0M | $9.6M | $15.4M | $18.9M | $25.0M | $8.9M | $18.7M | $18.2M | $22.7M | $27.0M |
| Property, plant & equipment (net) | $5,000 | $6,000 | $7,000 | $7,000 | $8,000 | $9,000 | $10,000 | $12,000 | $14,000 | $18,000 | $22,000 | $26,000 |
| Goodwill & intangible assets | $2.4M | $2.5M | $2.5M | $2.6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1,000 | $1,000 | $104,000 | $240,000 | $244,000 | $198,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 |
| Total assets | $11.5M | $8.2M | $10.6M | $12.4M | $15.6M | $19.1M | $25.0M | $8.9M | $18.7M | $18.2M | $22.7M | $27.0M |
| Liabilities | ||||||||||||
| Accounts payable | $6.3M | $7.7M | $5.7M | $5.1M | $4.8M | $7.7M | $8.2M | $5.5M | $6.2M | $6.6M | $5.6M | $6.1M |
| Deferred revenue | — | — | — | — | — | $226,000 | $226,000 | $226,000 | $227,000 | $226,000 | $226,000 | $226,000 |
| Total current liabilities | $9.7M | $13.2M | $11.1M | $7.9M | $7.4M | $10.4M | $11.5M | $8.3M | $9.9M | $9.4M | $9.2M | $9.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $44,000 | $259,000 | $100,000 | $11,000 | $8,000 | $2.7M | $45.1M | $2.6M | $114.3M | $2.7M | $2.8M | $2.8M |
| Total liabilities | $9.8M | $13.5M | $11.2M | $7.9M | $7.4M | $13.1M | $56.6M | $11.0M | $124.2M | $12.2M | $12.0M | $12.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | — | $101,000 | — | $71,000 | $71,000 | $50,000 | $36,000 | $30,000 | $253,000 | $211,000 | $210,000 | $210,000 |
| Retained earnings (deficit) | −$650.1M | −$647.1M | −$640.0M | −$632.5M | −$628.6M | −$627.7M | −$649.2M | −$619.2M | −$610.8M | −$487.6M | −$482.6M | −$478.4M |
| Accumulated other comprehensive income | — | −$2,000 | — | $6,000 | $9,000 | −$19,000 | −$42,000 | −$33,000 | −$33,000 | −$30,000 | −$23,000 | −$30,000 |
| Total shareholders' equity | $1.7M | −$5.3M | −$629,000 | $4.5M | $8.3M | $6.0M | −$31.6M | −$2.0M | −$105.5M | $6.0M | $10.7M | $14.5M |
| Key figures | ||||||||||||
| Working capital | −$712,000 | −$7.5M | −$3.2M | $1.7M | $8.0M | $8.5M | $13.4M | $575,000 | $8.8M | $8.7M | $13.4M | $17.3M |
| Tangible book value | −$750,000 | −$7.8M | −$3.2M | $2.0M | $8.3M | $6.0M | −$31.6M | −$2.0M | −$105.5M | $6.0M | $10.7M | $14.5M |
| Book value per share | $0.11 | −$0.50 | −$0.07 | $0.52 | $1.42 | $0.83 | — | — | — | — | — | — |
| Shares outstanding | 15.3M | 10.6M | 9.1M | 8.8M | 5.8M | 7.2M | — | — | — | — | — | — |
| Current ratio | 0.93 | 0.43 | 0.72 | 1.22 | 2.09 | 1.81 | 2.16 | 1.07 | 1.88 | 1.93 | 2.46 | 2.79 |
| Quick ratio | 0.52 | 0.36 | 0.68 | 1.07 | 1.96 | 1.69 | 2.00 | 0.90 | 1.71 | 1.74 | 2.26 | 2.61 |
| Equity / assets | 14.7% | −65.1% | −5.9% | 36.5% | 52.9% | 31.5% | −126.7% | −22.8% | −564.7% | 33.1% | 47.0% | 53.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 15, 2026); data from EODHD.
TRAW financial position
At the end of fiscal 2025 (December 31, 2025), Traws Pharma had total assets of $10.6 million (down 57.5% from a year earlier), total liabilities of $11.2 million and shareholders' equity of -$0.6 million. Its current ratio was 0.72. In the latest quarter (ended June 30, 2026) total assets were $11.5 million and equity $1.7 million.
Related: TRAW income statement, TRAW cash flow statement, TRAW key metrics. See the TRAW stock overview for the latest quote and news.
TRAW balance sheet FAQ
What are Traws Pharma's total assets?
Traws Pharma reported total assets of $10.6 million at the end of fiscal 2025 (December 31, 2025), compared with $25.0 million a year earlier.
How much cash does Traws Pharma have?
Traws Pharma held $3.8 million in cash and short-term investments at the end of fiscal 2025.
What is Traws Pharma's book value?
Traws Pharma's shareholders' equity (book value) was -$0.6 million at the end of fiscal 2025, or −$0.08 per share.
What is Traws Pharma's current ratio?
Traws Pharma had current assets of $8.0 million and current liabilities of $11.1 million, a current ratio of 0.72 (current liabilities exceed current assets).
How much goodwill does Traws Pharma have?
Traws Pharma carried $2.5 million of goodwill and intangible assets, 23.8% of total assets, at the end of fiscal 2025.